At the Global Health Summit, the G20, invited leaders, heads of international and regional organisations, and representatives of global health bodies, will share lessons learned from the COVID-19 pandemic.
Their goal is to create a ‘Rome Declaration’ including principles which can be a powerful guide for medium to long-term structural change brought about through international cooperation and joint action to prevent future global health crises.
It is crucial that these principles are evidence based. Their definition will therefore be informed by a scientific expert panel, and take into account the views of civil society.
To achieve that, the European Commission and the Italian G20 Presidency have set up a High Level Scientific Panel.
It gathers 26 senior scientific experts from around the world, experienced in local and global COVID-19 response and science advice to policy at the highest levels. They participate in their personal capacities and bring broad and diverse experience obtained in different countries and regions.
The Panel will present its findings to attendees at the Global Health Summit.
Report of the Global Health Summit Scientific Expert Panel
Professor Peter Piot
Special adviser to the President of the European Commission Ursula von der Leyen
President of the Italian National Institute of Health
President of the United States National Academy of Medicine
Director of the National Centre for Infectious Diseases in Singapore
Director of the Africa Centers for Disease Control and Prevention
Director of the European Centre for Disease Prevention and Control (ECDC), Germany
Assistant Deputy Minister for Preventive Services, Saudi Ministry of Health, Saudi Arabia
Director-General of Fakhr Al Watan Office (Frontline Heroes Office), United Arab Emirates
Co-Director of the Centre for global health practice and impact, Georgetown; and member of Independent Panel for Pandemic Preparedness and Response, USA
Director of the Wellcome Trust, and member of the UK government’s Scientific Advisory Group for Emergencies (SAGE), the UK Vaccine Taskforce and the Principles Group of the ACT-Accelerator, and chair of the WHO R&D Blueprint Advisory Group, United-Kingdom
Member of the French COVID-19 scientific council and Director at the Institut Pasteur, France
Director-General of the Chinese Center for Disease Control and Prevention, China
Professor at the School of Public Health at Cayetano Heredia University (UPCH) in Lima, Peru. Former Minister of Health of Peru, Dean of the School of Public Health at UPCH, and former Chief of the Peruvian National Institute of Health (INS), Peru
Co-Chair of Canada’s COVID-19 Immunity Task Force and Deputy Director, Science at the Amsterdam Institute for Global Health and Development, Department of Global Health, University of Amsterdam, Canada
Co-chair of the ministerial advisory committee (MAC) on COVID-19, South Africa
President of the Bill and Melinda Gates Global Health Program, USA
Co-Chair of the Africa Union Africa Vaccine Delivery Alliance for COVID-19, Nigeria
Chairperson of the Italian Medicine Agency, Italy
Director of the Institut Pasteur in Dakar, Senegal
Chief Scientist at the World Health Organization (WHO)
Director-General of the Norwegian Institute of Public Health, Norway
Principal Scientific Advisor to the Government of India and member of the Global Preparedness Monitoring Board (GPMB), India
Director-General of the National Institute of Infectious Disease, Japan
President of the Robert Koch Institute, Berlin, Germany
Chief Medical Officer of the Centers for Disease Control Control and Prevention, USA
Chief Epidemiologist with Chinese Center for Disease Control and Prevention, China